What "Dementia" Actually Means — And Why It Matters

Dementia is not a single disease. It is an umbrella term — a broad clinical descriptor — used to describe a group of symptoms that affect memory, thinking, communication, and the ability to carry out daily activities well enough to interfere with everyday life. Understanding this distinction is the first step toward finding the right care for your loved one.

Think of it this way: "dementia" is to brain disease what "cancer" is to tumors. Just as there are many types of cancer, there are many types of dementia — and Alzheimer's disease is the most common one. According to the Alzheimer's Association 2025 Facts and Figures report, an estimated 6.9 million Americans age 65 and older are living with Alzheimer's disease alone, and that number is expected to rise to 13.8 million by 2060 unless medical advances change the trajectory.

Why Families Often Confuse the Two Terms

In everyday conversation — and even in many physician's offices — "dementia" and "Alzheimer's" are often used interchangeably. This is understandable, because Alzheimer's disease accounts for an estimated 60–80% of all dementia cases (Alzheimer's Association, 2025). But the distinction matters enormously when it comes to treatment, care planning, and understanding what to expect in the months and years ahead.

The Role of Cognitive Decline

All forms of dementia involve progressive cognitive decline — meaning the symptoms typically worsen over time. However, the rate of decline, the type of symptoms that appear first, and the parts of the brain affected vary significantly depending on the underlying cause. This is why an accurate diagnosis matters so much, and why families in Katy, TX should work with a qualified neurologist or geriatric specialist before drawing conclusions.

Dementia Is a Syndrome, Not a Disease

Medical professionals describe dementia as a "syndrome" — a collection of symptoms with multiple possible causes. Those causes include Alzheimer's disease, Lewy body disease, vascular damage, Parkinson's disease, frontotemporal degeneration, and others. Identifying the cause changes everything about how care is provided.

Dementia and Alzheimer's: The Core Difference Explained

The single most important thing to understand about dementia and Alzheimer's is this: every person with Alzheimer's has dementia, but not every person with dementia has Alzheimer's. Alzheimer's disease is one specific cause of dementia — the most prevalent one — but it is not the only one.

Alzheimer's Disease Defined

Alzheimer's disease (AD) is a progressive, degenerative brain disease caused by abnormal deposits of proteins in and around brain cells. These deposits — called amyloid plaques and tau tangles — disrupt the way brain cells communicate, and eventually cause cell death. The damage typically begins in the hippocampus, the region of the brain responsible for forming new memories, which is why short-term memory loss is usually one of the earliest signs.

Dementia Defined

Dementia, by contrast, is the clinical label applied when a person's cognitive symptoms — memory loss, confusion, difficulty with language, impaired judgment, or changes in personality — are severe enough to interfere with daily function. It is diagnosed based on observed symptoms, not by a specific biological marker (though this is changing with advances in biomarker testing).

Can You Have Dementia Without Alzheimer's?

Yes — and this is critically important for families. Many people living with Lewy body dementia, vascular dementia, or frontotemporal dementia are sometimes told (incorrectly) that they "have Alzheimer's" simply because the diagnosis of another form of dementia is less familiar to the general public. Getting the right diagnosis leads to better-targeted treatment and more accurate care planning.

Types of Dementia Families in Katy, TX Should Know

There are more than a dozen recognized forms of dementia. For families in Katy, TX navigating a new diagnosis, understanding the most common types can help clarify what to expect and what treatment pathways are most likely to be explored by your loved one's medical team.

Alzheimer's Disease

As noted, Alzheimer's is the most common form of dementia, accounting for the majority of cases. It progresses through recognizable stages (discussed in Section 4), and is associated with gradual memory loss that worsens over time, alongside changes in mood, language, and behavior.

Vascular Dementia

Vascular dementia is the second most common form, caused by reduced blood flow to the brain — often following a stroke or series of mini-strokes (transient ischemic attacks). Unlike Alzheimer's, vascular dementia may progress in a more "stepwise" fashion, with periods of stability followed by sudden decline. Managing cardiovascular risk factors (blood pressure, cholesterol, blood sugar) is central to slowing its progression.

Lewy Body Dementia

Lewy body dementia (LBD) is caused by abnormal deposits of alpha-synuclein protein (called Lewy bodies) in the brain. It is often characterized by vivid visual hallucinations, significant fluctuations in alertness, and Parkinsonian motor symptoms (tremor, stiffness, slowness). It is notoriously underdiagnosed and requires careful medication management, as many standard antipsychotic drugs used in other dementias can be dangerous for people with LBD.

Frontotemporal Dementia

Frontotemporal dementia (FTD) affects the frontal and temporal lobes of the brain, and tends to strike at younger ages — sometimes as early as the 40s or 50s. Rather than memory loss, the earliest signs are often changes in personality, behavior, and language. People with FTD may become uncharacteristically impulsive, socially inappropriate, or lose the ability to speak fluently.

Source: Alzheimer's Association 2025 Facts and Figures; World Health Organization (WHO) 2025.

Stages of Alzheimer's Disease: A Practical Overview

Alzheimer's disease is a progressive condition, which means it changes over time — typically across three broad stages: early (mild), middle (moderate), and late (severe). Understanding these stages helps families in Katy, TX plan ahead, make timely decisions about care transitions, and set realistic expectations.

Early Stage (Mild Alzheimer's)

In the early stage, many people with Alzheimer's can still live independently, drive, and participate in meaningful activities. However, they may notice — and family members may begin to observe — memory lapses that go beyond normal aging. These include:

• Forgetting words or names during conversation
• Losing track of recent conversations or appointments
• Repeating questions or stories within the same conversation
• Difficulty with planning, organizing, or problem-solving
• Misplacing objects in unusual places

This stage can last for years and is often when families begin their research into care options — including resources like Evergreen Cottages in Katy, TX.

Middle Stage (Moderate Alzheimer's)

The middle stage is typically the longest phase and the one where the need for increased support becomes clear. Symptoms become more pronounced and may include:

• Increasing memory loss, including of personal history
• Confusion about the date, season, or location
• Difficulty recognizing family members and close friends
• Wandering and becoming lost in familiar surroundings
• Changes in sleep patterns (sundowning)
• Personality changes: suspicion, depression, anxiety, agitation
• Needing help with daily activities like dressing, bathing, and toileting

Late Stage (Severe Alzheimer's)

In the late stage, individuals require around-the-clock care. They may lose the ability to communicate verbally, become vulnerable to infections, and lose the ability to walk or swallow safely. The primary focus of care shifts from cognitive engagement to comfort, dignity, and physical wellbeing. This is when many families in the Katy, TX area turn to dedicated memory care communities for full-time professional support.

Dementia and Alzheimer's Symptoms: Side-by-Side Comparison

One of the most common questions families ask when researching dementia and Alzheimer's is: "How do I know which one my loved one has?" The answer lies in symptoms, timing, and the formal diagnostic process — but this comparison table can help you begin to see the distinctions more clearly.

Shared Symptoms Across Most Dementias

Because most dementias affect the brain's ability to process, store, and retrieve information, there is significant overlap in symptoms. These shared signs include:

• Memory lapses that disrupt daily life
• Difficulty with familiar tasks
• Confusion with time or place
• Problems with language or word-finding
• Withdrawal from social activities
• Changes in mood or personality
• Poor judgment and decision-making

Symptoms That Distinguish Alzheimer's

Alzheimer's-specific symptoms — particularly in the early and middle stages — tend to center on episodic memory (the memory of specific recent events). People with Alzheimer's often remember the distant past vividly while struggling to recall what happened an hour ago. They may ask the same question repeatedly without awareness that they have already asked it.

Symptoms That Point to Other Dementias

Other forms of dementia may present differently in meaningful ways:

Source: Alzheimer's Association 2025 Facts and Figures; LeadingAge 2025 Field Guide to Dementia Care.

How Alzheimer's Disease Is Diagnosed

There is no single test that definitively diagnoses Alzheimer's disease during a person's lifetime. Instead, diagnosis involves a combination of medical history, cognitive testing, brain imaging, and increasingly, biomarker analysis. The goal is to rule out other causes and identify the characteristic patterns of Alzheimer's pathology.

Cognitive and Neuropsychological Testing

The diagnostic process typically begins with structured cognitive assessments administered by a physician or neuropsychologist. Common tools include the Mini-Mental State Examination (MMSE), the Montreal Cognitive Assessment (MoCA), and the Clinical Dementia Rating scale (CDR). These tests evaluate memory, attention, language, visuospatial skills, and executive function, helping clinicians understand the pattern and degree of cognitive impairment.

Brain Imaging

Structural imaging — typically an MRI — is used to look for evidence of brain atrophy (shrinkage), particularly in the hippocampus and entorhinal cortex, which are affected early in Alzheimer's. CT scans may also be used to rule out other causes such as tumors, strokes, or bleeding. PET scans using amyloid tracers can now detect the presence of amyloid plaques in the brain — a hallmark of Alzheimer's disease — and are increasingly used in research and clinical settings.

Biomarker Testing and the Lecanemab Era

One of the most significant recent advances in Alzheimer's diagnostics is the development of blood-based biomarker tests that can detect phosphorylated tau (p-tau217) — a protein associated with Alzheimer's pathology. According to the Alzheimer's Association 2025 Facts and Figures report, these tests are rapidly moving toward clinical use and may soon allow primary care physicians in Katy, TX and beyond to screen for Alzheimer's disease with a simple blood draw, dramatically reducing the time to diagnosis.

Ruling Out Reversible Causes

Before a diagnosis of Alzheimer's or any dementia is confirmed, physicians must rule out conditions that can mimic dementia symptoms but are potentially reversible: thyroid disease, vitamin B12 deficiency, urinary tract infections (UTIs — especially common in older women), medication side effects, depression, and sleep disorders. This step is critical and should never be skipped.

How Non-Alzheimer's Dementias Are Diagnosed

Diagnosing dementia types other than Alzheimer's often requires a higher level of specialist involvement and a more nuanced diagnostic workup. Because many non-Alzheimer's dementias have overlapping features, misdiagnosis is unfortunately common — making it worth advocating for a comprehensive evaluation if something doesn't feel right about an initial diagnosis.

Diagnosing Vascular Dementia

Vascular dementia is typically diagnosed through a combination of cognitive assessment and brain imaging. MRI or CT scans can reveal areas of the brain that have been damaged by strokes, small vessel disease, or insufficient blood flow. Cardiovascular risk factor history — including hypertension, diabetes, and atrial fibrillation — is carefully reviewed, since these conditions dramatically increase vascular dementia risk.

Diagnosing Lewy Body Dementia

Lewy body dementia (LBD) is among the most underdiagnosed forms of dementia, with an average delay of more than three years between symptom onset and correct diagnosis, according to the Lewy Body Dementia Association (LBDA). Diagnosis involves clinical criteria including the presence of at least two of its core features: fluctuating cognition, recurrent visual hallucinations, REM sleep behavior disorder, and Parkinsonism. DaTscan imaging (which examines dopamine transporter activity) can support the diagnosis.

Diagnosing Frontotemporal Dementia

FTD is often misdiagnosed as depression, bipolar disorder, or even Alzheimer's in its early stages, because behavioral and personality symptoms are more prominent than memory loss. Neuropsychological testing, family history review, and advanced MRI or PET imaging showing frontal and temporal lobe atrophy or hypometabolism are the primary diagnostic tools. Genetic testing may be recommended in younger patients or those with a strong family history.

Treating Alzheimer's Disease: What Families Can Expect

There is currently no cure for Alzheimer's disease. However, that does not mean nothing can be done. A growing number of FDA-approved medications — alongside non-pharmacological strategies — can slow the progression of symptoms, preserve quality of life, and manage the behavioral challenges that often accompany the disease. Treatment is most effective when started as early as possible.

FDA-Approved Medications for Alzheimer's

The U.S. Food and Drug Administration (FDA) has approved several medications specifically for Alzheimer's disease. These fall into two categories:

1. Cholinesterase Inhibitors (donepezil, rivastigmine, galantamine) work by preventing the breakdown of acetylcholine, a chemical messenger involved in memory and learning. They are typically prescribed in the mild-to-moderate stages and can help stabilize symptoms for months to years in some individuals.

2. Memantine (Namenda) works by regulating glutamate activity in the brain and is typically used in moderate-to-severe Alzheimer's, sometimes in combination with a cholinesterase inhibitor.

3. Anti-amyloid therapies represent a newer and more groundbreaking class of treatment. Lecanemab (Leqembi), approved by the FDA in 2023, is a monoclonal antibody that targets and removes amyloid plaques from the brain. Clinical trials showed it slowed the rate of cognitive decline by approximately 27% in people with early Alzheimer's (New England Journal of Medicine, 2023). Donanemab is another anti-amyloid therapy that received FDA accelerated approval in 2024.

Managing Behavioral and Psychological Symptoms

Alzheimer's disease often produces behavioral and psychological symptoms — collectively known as BPSD — including agitation, aggression, depression, anxiety, sleep disturbance, and wandering. These can be among the most exhausting aspects of caregiving. Management typically involves:

• Non-pharmacological approaches first: structured routines, sensory activities, music therapy, validation therapy, environmental modifications
• Medication when necessary: antidepressants, anxiolytics, or in specific cases, low-dose antipsychotics (used with caution)

The Role of Structured Programming in Alzheimer's Care

Research consistently shows that structured, purposeful activity — tailored to the individual's abilities and life history — can reduce agitation, improve mood, and slow functional decline in people with Alzheimer's. This is why memory care communities like Evergreen Cottages in Katy, TX invest heavily in individualized activity programming, music therapy, and sensory enrichment as core components of care — not optional extras.

Treating Other Forms of Dementia: Key Differences in Approach

Treatment for non-Alzheimer's dementias diverges significantly from Alzheimer's care in important ways. Getting the diagnosis right is the foundation of getting the treatment right — and certain medications that help Alzheimer's patients can actually be harmful in other types of dementia.

Treating Vascular Dementia

Unlike Alzheimer's disease, vascular dementia does not have FDA-approved medications specifically designed for it. Treatment focuses primarily on preventing further vascular damage — which means aggressively managing the underlying conditions that caused the blood flow disruption in the first place:

• Blood pressure control (hypertension is the single biggest modifiable risk factor)
• Management of diabetes and cholesterol levels
• Antiplatelet or anticoagulant therapy to reduce stroke risk
• Smoking cessation and heart-healthy lifestyle modifications

Some clinicians also use cholinesterase inhibitors off-label for vascular dementia, with modest benefit in some patients. Cognitive rehabilitation and structured daily routines — core offerings at Evergreen Cottages — play an important role in maintaining function.

Treating Lewy Body Dementia — Proceed with Caution

Lewy body dementia requires the most careful medication management of any dementia type. People with LBD are hypersensitive to traditional antipsychotic medications — drugs like haloperidol or risperidone that are sometimes used to manage behavioral symptoms in other dementias can trigger severe and potentially life-threatening reactions in people with LBD, including extreme muscle rigidity, high fever, and loss of consciousness.

Instead, treatment for LBD typically includes:

• Cholinesterase inhibitors (rivastigmine is often particularly well-tolerated)
• Levodopa (for Parkinsonian motor symptoms) — used carefully
• Clonazepam for REM sleep behavior disorder
• Non-pharmacological strategies for hallucinations (reassurance, environment modification)

Treating Frontotemporal Dementia

There are no FDA-approved medications specifically for FTD, and cholinesterase inhibitors are generally not recommended and may worsen behavioral symptoms. Treatment is largely focused on managing the behavioral changes through:

• Selective serotonin reuptake inhibitors (SSRIs) for compulsive behaviors and depression
• Speech therapy for language-variant FTD
• Behavioral management strategies for caregivers
• Structured daily routines to reduce frustration and outbursts

Lifestyle Interventions That Support Both Dementia and Alzheimer's Care

Beyond medications, a growing body of research confirms that lifestyle interventions — diet, physical activity, social engagement, cognitive stimulation, sleep, and stress management — can meaningfully support brain health, slow cognitive decline, and improve quality of life for people living with dementia and Alzheimer's. These are not alternative treatments; they are evidence-based complements to medical care.

The Role of Diet

Nutritional science has identified several dietary patterns associated with reduced dementia risk and slower progression. The MIND diet (Mediterranean-DASH Intervention for Neurodegenerative Delay) — a hybrid of the Mediterranean and DASH diets — has been associated with a significantly lower rate of cognitive decline in older adults, according to research published in Alzheimer's & Dementia (Morris et al., 2015; updated 2023 validation). Key components include:

• Leafy green vegetables (at least 6 servings per week)
• Berries (especially blueberries and strawberries)
• Nuts and olive oil
• Fish (at least once per week)
• Whole grains and beans
• Limited red meat, butter, cheese, sweets, and fried foods

At Evergreen Cottages in Katy, TX, our kitchen team is informed by brain-healthy nutritional principles to ensure that every meal served supports our residents' cognitive and physical wellbeing.

Physical Activity

Regular aerobic exercise has been shown to increase the size of the hippocampus — the brain's memory center — and improve cognitive function even in people with existing dementia. According to a landmark study published in the British Journal of Sports Medicine (2023), engaging in 150 minutes of moderate aerobic activity per week was associated with a 35% lower risk of dementia. Even gentle movement — walking, stretching, chair yoga — is beneficial for residents in memory care settings.

Social Engagement and Cognitive Stimulation

Social isolation is now recognized as one of the most significant modifiable risk factors for dementia. The National Institute on Aging (NIA) estimates that loneliness and social isolation increase dementia risk by as much as 50%. In contrast, maintaining meaningful social connections — through conversation, group activities, music, games, and shared meals — supports cognitive reserve and emotional wellbeing. This is one of the most compelling arguments for memory care community living versus isolated home care.

Sleep and Stress

Disrupted sleep and chronic stress both accelerate cognitive decline. During deep sleep, the brain's glymphatic system clears toxic waste products — including amyloid and tau proteins — from brain tissue.